Kiyono Y - Search Results

1

Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.

Kiyono Y, Sugita T, Ueda M, Kawashima H, Kanegawa N, Kuge Y, Fujibayashi Y, Saji H. Kiyono Y, et al. Nucl Med Biol. 2008 Feb;35(2):213-8. doi: 10.1016/j.nucmedbio.2007.11.006. Nucl Med Biol. 2008. PMID: 18312831

2

Application of [125I] (S)-5-iodonicotine, a new radioiodinated ligand, in the assay of nicotinic acetylcholine receptor binding in the brain.

Saji H, Watanabe A, Kiyono Y, Magata Y, Iida Y, Takaishi Y, Yokoyama A. Saji H, et al. Among authors: kiyono y. Biol Pharm Bull. 1995 Nov;18(11):1463-6. doi: 10.1248/bpb.18.1463. Biol Pharm Bull. 1995. PMID: 8593459 Free article.

3

Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography.

Saji H, Watanabe A, Magata Y, Ohmomo Y, Kiyono Y, Yamada Y, Iida Y, Yonekura Y, Konishi J, Yokoyama A. Saji H, et al. Among authors: kiyono y. Chem Pharm Bull (Tokyo). 1997 Feb;45(2):284-90. doi: 10.1248/cpb.45.284. Chem Pharm Bull (Tokyo). 1997. PMID: 9118442

4

Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.

Kiyono Y, Iida Y, Kawashima H, Tamaki N, Nishimura H, Saji H. Kiyono Y, et al. Eur J Nucl Med. 2001 Jul;28(7):894-9. doi: 10.1007/s002590100550. Eur J Nucl Med. 2001. PMID: 11504086

5

Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.

Saji H, Ogawa M, Ueda M, Iida Y, Magata Y, Tominaga A, Kawashima H, Kitamura Y, Nakagawa M, Kiyono Y, Mukai T. Saji H, et al. Among authors: kiyono y. Ann Nucl Med. 2002 May;16(3):189-200. doi: 10.1007/BF02996300. Ann Nucl Med. 2002. PMID: 12126044

6

Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.

Kiyono Y, Iida Y, Kawashima H, Ogawa M, Tamaki N, Nishimura H, Saji H. Kiyono Y, et al. Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):999-1005. doi: 10.1007/s00259-002-0798-1. Epub 2002 May 17. Eur J Nucl Med Mol Imaging. 2002. PMID: 12173012

7

Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol: studies using [3H]HPP+.

Kawashima H, Iida Y, Kitamura Y, Kiyono Y, Magata Y, Saji H. Kawashima H, et al. Among authors: kiyono y. Jpn J Pharmacol. 2002 Aug;89(4):426-8. doi: 10.1254/jjp.89.426. Jpn J Pharmacol. 2002. PMID: 12233823 Free article.

8

Kiyono Y, Kanegawa N, Kawashima H, Iida Y, Kinoshita T, Tamaki N, Nishimura H, Ogawa M, Saji H. Kiyono Y, et al. Nucl Med Biol. 2002 Aug;29(6):679-84. doi: 10.1016/s0969-8051(02)00309-8. Nucl Med Biol. 2002. PMID: 12234593

9

A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine.

Kiyono Y, Kanegawa N, Kawashima H, Fujiwara H, Iida Y, Nishimura H, Saji H. Kiyono Y, et al. Nucl Med Biol. 2003 Oct;30(7):697-706. doi: 10.1016/s0969-8051(03)00085-4. Nucl Med Biol. 2003. PMID: 14499327

10

Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imaging.

Kiyono Y, Kanegawa N, Kawashima H, Kitamura Y, Iida Y, Saji H. Kiyono Y, et al. Nucl Med Biol. 2004 Feb;31(2):147-53. doi: 10.1016/j.nucmedbio.2003.09.004. Nucl Med Biol. 2004. PMID: 15013479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters